Gene · 1382
CRABP2: cellular retinoic acid binding protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CRABP2: cellular retinoic acid binding protein 2. Genes, record 1382. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1382
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P29373 | Cellular retinoic acid-binding protein 2 | 138 | 85 | Ensembl, GeneID, HGNC |
Source UniProt
Patents67
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40812 | P29373 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40813 | P29373 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8413 | P29373 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8413 | P29373 | Espacenet |
| US 12024722 B2 | 2024-07-02 | 8 | P29373 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13832 | P29373 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13833 | P29373 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13834 | P29373 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116803 | P29373 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 116804 | P29373 | Espacenet |
1 to 10 of 67
See all 67 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants871
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CRABP2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| ZIABC005708 | Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers | 6 | 2025 |
| ZIABC005562 | Xenobiotic receptors | 5 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 4 | 2025 |
| K12HD050121 | Research Career Development in Obstetrics and Gynecology | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 3 | 2025 |
| R01DK046335 | Probing the biochemical mechanism of amyloid disease | 3 | 2025 |
| R01DK122071 | RBP2 Biology and Pathobiology | 3 | 2025 |
| R01NS098273 | Development and function of the meninges arachnoid barrier | 3 | 2025 |
1 to 10 of 871Source NIH's project files
See all 871 nih grantsPapers1,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma. | J Immunother Cancer | 2026 | 42767768 | PubTator, text mining | PubMed |
| Clinicopathologic features of spinal arachnoiditis in patients with surgically treated syringomyelia: A retrospective study of 60 cases. | J Neuropathol Exp Neurol | 2026 | 42658566 | PubTator, text mining | PubMed |
| Causal link between polymyositis and idiopathic pulmonary fibrosis in individuals of European ancestry: A Mendelian randomization and multi-omics study identifying mediators and drug targets. | Medicine (Baltimore) | 2026 | 42629724 | PubTator, text mining | PubMed |
| Cellular Retinoic Acid-Binding Protein 2 Promotes Ischemia-Induced Cardiac Fibroblast Activation and Fibrosis Through Suppression of MRE11-RAD50-NBS1-Mediated DNA Repair. | J Am Heart Assoc | 2026 | 42535577 | PubTator, text mining | PubMed |
| CRABP2 Promotes Lung Adenocarcinoma Through Retinoic Acid Pathway-Mediated NF-κB Activation. | Front Biosci (Landmark Ed) | 2026 | 42530247 | PubTator, text mining | PubMed |
| Oxymatrine Synergizes with 5-fluorouracil to Inhibit the Proliferation of A549 Cells by Targeting APE1. | Curr Med Chem | 2026 | 42522309 | PubTator, text mining | PubMed |
| The dual role of retinoic acid signaling in clear cell renal cell carcinoma and wilms tumor: A tale of two entities. | Biochim Biophys Acta Rev Cancer | 2026 | 42492627 | PubTator, text mining | PubMed |
| The CRABP2-MDK Signaling Axis Promotes Lung Adenocarcinoma (LUAD) Progression and Highlights Prognostic Biomarkers. | Mol Carcinog | 2026 | 42472388 | PubTator, text mining | PubMed |
| Single-cell and machine learning-based neural regulation signature for prognosis prediction and immunotherapy response in lung adenocarcinoma. | Transl Oncol | 2026 | 42391672 | PubTator, text mining | PubMed |
| Fatty acid-binding protein 5 (FABP5) modulates limbal epithelial cell homeostasis by regulating the expression of key genes under both normal and inflammatory conditions, in vitro. | PLoS One | 2026 | 42048350 | PubTator, text mining | PubMed |
1 to 10 of 1,285
See all 1,285 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1382
GET https://conductscience.org/api/genes/v1/1382/patents?page=2